首页> 美国卫生研究院文献>BMC Infectious Diseases >Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature
【2h】

Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature

机译:慢性结核性脓胸的治疗药物监测和保守治疗:病例报告和文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundChronic tuberculous empyema (CTE) is a rare and unusual, low grade and protracted, infection of the pleural space resulting in marked thickening, even calcification of the visceral and parietal pleura. Historically its management has been extraordinarily challenging. Differential penetration of anti-TB drugs into the pleural space has resulted in acquired drug resistance and surgery to remove the empyema or close a complicating bronchopleural fistula (BPF) has been technically difficult or unacceptably hazardous. On the basis of limited experience, the combination of tube thoracostomy or catheter drainage and high-end dosing of anti-TB drugs has been recommended as an initial approach to these lesions. Herein we report the first well documented case of closure of a BPF and cure of a CTE using this approach. The chances of a favorable outcome are improved, we suggest, by using therapeutic drug monitoring (TDM) to guide high-end drug dosing.
机译:背景慢性结核性脓胸(CTE)是一种罕见且不寻常的,低度且长期的胸膜腔感染,导致内脏和顶叶胸膜明显增厚甚至钙化。从历史上看,它的管理非常困难。抗结核药物向胸膜间隙的差异渗透已导致获得性耐药性,并且去除脓胸或关闭复杂的支气管胸膜瘘(BPF)的手术在技术上是困难的或无法接受的。基于有限的经验,建议将开胸胸腔切开术或导管引流与抗结核药物高端给药相结合作为治疗这些病变的初始方法。本文中,我们报道了使用这种方法封闭BPF和治愈CTE的第一个有据可查的案例。我们建议,通过使用治疗药物监测(TDM)指导高端药物剂量,可以改善获得有利结果的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号